5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)HIV-1 InfectionActive, not recruitingPhase 32026-10-05NCT05705349
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightBody Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutritionActive, not recruitingPhase 32026-09-30NCT05567796
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious diseaseActive, not recruitingPhase 32026-09-17NCT07159763
Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary TuberculosisDrug Susceptible Pulmonary TuberculosisRecruitingPhase 22026-07-30NCT07525427
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCVBlood-Borne Infections, Chronic Disease, Digestive System Diseases, Disease Attributes, Flaviviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, chronic hepatitis C virus infection, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious diseaseActive, not recruitingPhase 32026-06-29NCT07037277